Steven A. Wartman, president and CEO of the Association of Academic Wellness Centers , urged Senate Majority Leader Harry Reid to make sure that wellness reform create a, coordinated national health workforce policy by incorporating four AAHC suggestions into Senate wellness reform legislation. ‘. House Speaker Pelosi released a wellness reform bill that now incorporates the first of the recommendations,’ Wartman stated in a letter to Reid this full week. ‘The AAHC urges you to include all four suggestions in any wellness reform legislation planned for a Senate flooring vote.’ After reviewing pending health reform expenses, the AAHC recommends that four adjustments be produced to any health reform legislation voted on by the House and Senate: Make development and implementation of a, coordinated, strategic national health workforce policy the principal objective of any advisory committee or national commission.Amend the set of enumerated concerns to be addressed by the advisory committee or nationwide commission to include the harmonization of conflicting national and state-based regulatory and private self-regulatory standards .Constitute the advisory committee or national commission as a constantly available policy research and consultative source, not only as a body of external experts that convenes every once in awhile to create periodic recommendations.As an interim step until an advisory committee or national commission is fully functional, create a national health workforce coordinator to assess current federal capabilities and prepare agencies for their interactions with the committee/commission.Related StoriesXeno-free of charge and endotoxin-free individual cytokinesProtein delivery reagent assists neurodegeneration researchGuide to organoid growth Dr Erik Miljan, founding director of Simply Cells Ltd assesses the effect on the physiological relevance of in vitro cell structured versions using traditional ECM proteins, recombinant biomimetics hydrogels and various other matrices like polystyrene scaffolds in drug disease and discovery modeling applications. Highlighting real examples including neuronal and spheroid stem cell culture, Dr Miljan demonstrates how different 3D technologies could be put on specific needs of researchers.